HPTLC determination of ketorolac tromethamine

被引:27
作者
Devarajan, PV [1 ]
Gore, SP [1 ]
Chavan, SV [1 ]
机构
[1] Univ Mumbai, Dept Chem Technol Autonomous, Pharmaceut Sci & Technol Div, Mumbai 400019, India
关键词
ketorolac tromethamine; HPTLC; saliva;
D O I
10.1016/S0731-7085(99)00296-4
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A High Performance Thin Layer Chromatography (HPTLC) method for quantification of ketorolac tromethamine, a non-narcotic and non-steroidal agent was developed. The mobile phase composition was chloroform-ethyl acetate-glacial acetic acid (3:8:0.1, v/v/v). Spectrodensitometric analysis of ketorolac tromethamine was carried out at 323 nm. The calibration curve was linear in the range of 200-700 ng. The mean values of slope, intercept and correlation coefficient were, 2941, 749583, 0.99. The method was validated for method precision, system precision, marketed sample analysis and recovery studies. The % CV for method precision studies was 1.98 (n = 6) and system precision study was 1.83 (n = 6). The average recovery was found to be 99.2%. Acid and base degraded products were adequately separated from the drug. The method was successfully used for the determination of drug from saliva. The results indicate that the method is simple, specific, selective and reliable for quantitative analysis of ketorolac tromethamine as bulk drug and from formulations. It can also be applied for the stability study of the drug and analysis of drug in biological fluids. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:679 / 683
页数:5
相关论文
共 14 条
[1]   Simultaneous determination of atenolol and nitrendipine in pharmaceutical dosage forms by HPTLC [J].
Argekar, AP ;
Sawant, JG .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1999, 22 (10) :1571-1578
[2]   RACEMIZATION OF KETOROLAC IN AQUEOUS-SOLUTION [J].
BRANDL, M ;
CONLEY, D ;
JOHNSON, D ;
JOHNSON, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (09) :1045-1048
[3]   KETOROLAC - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
BUCKLEY, MMT ;
BROGDEN, RN .
DRUGS, 1990, 39 (01) :86-109
[4]   Determination of the sleep aid ingredients diphenhydramine hydro chloride and doxylamine succinate in pharmaceutical products by quantitative HPTLC [J].
DiGregorio, D ;
Sherma, J .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1999, 22 (10) :1599-1606
[5]   COMPARATIVE BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF KETOROLAC TROMETHAMINE - DOLAC(R) AND EXODOL(R) [J].
FLORESMURRIETA, FJ ;
GRANADOSSOTO, V ;
CASTANEDAHERNANDEZ, G ;
HERRERA, JE ;
HONG, E .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (02) :129-136
[6]   COMPATIBILITY OF KETOROLAC TROMETHAMINE INJECTION WITH COMMON INFUSION FLUIDS AND ADMINISTRATION SETS [J].
FLOY, BJ ;
ROYKO, CG ;
FLEITMAN, JS .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (05) :1097-1100
[7]  
GU L, 1988, INT J PHARM, V41, P95
[8]   USE OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DIODE-ARRAY DETECTION IN FORENSIC TOXICOLOGY [J].
KOVES, EM .
JOURNAL OF CHROMATOGRAPHY A, 1995, 692 (1-2) :103-119
[9]  
KUMAR TRS, 1997, INDIAN DRUGS, V34, P532
[10]   ANALYSIS OF KETOROLAC IN POSTMORTEM BLOOD [J].
LOGAN, BK ;
FRIEL, PN ;
PETERSON, KL ;
PREDMORE, DB .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1995, 19 (02) :61-64